Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 180

1.

NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer.

Ding Y, Tong M, Liu S, Moscow JA, Tai HH.

Carcinogenesis. 2005 Jan;26(1):65-72. Epub 2004 Sep 9.

PMID:
15358636
[PubMed - indexed for MEDLINE]
Free Article
2.

Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancer.

Yang L, Amann JM, Kikuchi T, Porta R, Guix M, Gonzalez A, Park KH, Billheimer D, Arteaga CL, Tai HH, DuBois R, Carbone DP, Johnson DH.

Cancer Res. 2007 Jun 15;67(12):5587-93.

PMID:
17575121
[PubMed - indexed for MEDLINE]
Free Article
3.

Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells.

Tong M, Ding Y, Tai HH.

Carcinogenesis. 2006 Nov;27(11):2170-9. Epub 2006 Apr 22.

PMID:
16632868
[PubMed - indexed for MEDLINE]
Free Article
4.

NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer.

Hughes D, Otani T, Yang P, Newman RA, Yantiss RK, Altorki NK, Port JL, Yan M, Markowitz SD, Mazumdar M, Tai HH, Subbaramaiah K, Dannenberg AJ.

Cancer Prev Res (Phila). 2008 Sep;1(4):241-9. doi: 10.1158/1940-6207.CAPR-08-0055.

PMID:
19138967
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

15-hydroxyprostaglandin dehydrogenase (15-PGDH) and lung cancer.

Tai HH, Tong M, Ding Y.

Prostaglandins Other Lipid Mediat. 2007 May;83(3):203-8. Epub 2007 Jan 17. Review.

PMID:
17481556
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.

Wolf I, O'Kelly J, Rubinek T, Tong M, Nguyen A, Lin BT, Tai HH, Karlan BY, Koeffler HP.

Cancer Res. 2006 Aug 1;66(15):7818-23.

PMID:
16885386
[PubMed - indexed for MEDLINE]
Free Article
7.

Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha.

Otani T, Yamaguchi K, Scherl E, Du B, Tai HH, Greifer M, Petrovic L, Daikoku T, Dey SK, Subbaramaiah K, Dannenberg AJ.

Am J Physiol Gastrointest Liver Physiol. 2006 Feb;290(2):G361-8. Epub 2005 Sep 29.

PMID:
16195422
[PubMed - indexed for MEDLINE]
Free Article
8.
9.

Pioglitazone and rosiglitazone decrease prostaglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenase.

Hazra S, Batra RK, Tai HH, Sharma S, Cui X, Dubinett SM.

Mol Pharmacol. 2007 Jun;71(6):1715-20. Epub 2007 Apr 5.

PMID:
17412838
[PubMed - indexed for MEDLINE]
Free Article
10.

p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.

Katiyar SK, Meeran SM, Katiyar N, Akhtar S.

Mol Carcinog. 2009 Jan;48(1):24-37. doi: 10.1002/mc.20453.

PMID:
18459128
[PubMed - indexed for MEDLINE]
11.

Suppression of invasive properties of colorectal carcinoma SW480 cells by 15-hydroxyprostaglandin dehydrogenase gene.

Li M, Xie J, Cheng L, Chang B, Wang Y, Lan X, Zhang D, Yin Y, Cheng N.

Cancer Invest. 2008 Nov;26(9):905-12. doi: 10.1080/07357900802146154.

PMID:
19034772
[PubMed - indexed for MEDLINE]
12.

15-Hydroxyprostaglandin dehydrogenase is a tumor suppressor of human gastric cancer.

Liu Z, Wang X, Lu Y, Du R, Luo G, Wang J, Zhai H, Zhang F, Wen Q, Wu K, Fan D.

Cancer Biol Ther. 2010 Oct 15;10(8):780-7. Epub 2010 Oct 15.

PMID:
20699658
[PubMed - indexed for MEDLINE]
Free Article
13.

15-Hydroxyprostaglandin dehydrogenase suppresses K-RasV12-dependent tumor formation in Nu/Nu mice.

Pham H, Eibl G, Vincenti R, Chong B, Tai HH, Slice LW.

Mol Carcinog. 2008 Jun;47(6):466-77.

PMID:
18058808
[PubMed - indexed for MEDLINE]
14.

Altered expression of 15-hydroxyprostaglandin dehydrogenase in tumor-infiltrated CD11b myeloid cells: a mechanism for immune evasion in cancer.

Eruslanov E, Kaliberov S, Daurkin I, Kaliberova L, Buchsbaum D, Vieweg J, Kusmartsev S.

J Immunol. 2009 Jun 15;182(12):7548-57. doi: 10.4049/jimmunol.0802358.

PMID:
19494278
[PubMed - indexed for MEDLINE]
Free Article
16.

15-Hydroxyprostaglandin-dehydrogenase is involved in anti-proliferative effect of non-steroidal anti-inflammatory drugs COX-1 inhibitors on a human medullary thyroid carcinoma cell line.

Quidville V, Segond N, Lausson S, Frenkian M, Cohen R, Jullienne A.

Prostaglandins Other Lipid Mediat. 2006 Oct;81(1-2):14-30. Epub 2006 Sep 1.

PMID:
16997128
[PubMed - indexed for MEDLINE]
17.

Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs).

Tai HH, Chi X, Tong M.

Prostaglandins Other Lipid Mediat. 2011 Nov;96(1-4):37-40. doi: 10.1016/j.prostaglandins.2011.06.005. Epub 2011 Jul 6. Review.

PMID:
21763448
[PubMed - indexed for MEDLINE]
18.

Interleukin-4 up-regulates 15-hydroxyprostaglandin dehydrogenase (15-PGDH) in human lung cancer cells.

Chi X, Tai HH.

Exp Cell Res. 2010 Aug 15;316(14):2251-9.

PMID:
20632471
[PubMed - indexed for MEDLINE]
19.

Expression of 15-PGDH is downregulated by COX-2 in gastric cancer.

Liu Z, Wang X, Lu Y, Han S, Zhang F, Zhai H, Lei T, Liang J, Wang J, Wu K, Fan D.

Carcinogenesis. 2008 Jun;29(6):1219-27. doi: 10.1093/carcin/bgm297. Epub 2008 Jan 3.

PMID:
18174234
[PubMed - indexed for MEDLINE]
Free Article
20.

Prostaglandin E2 alterations during sepsis are partially mediated by endotoxin-induced inhibition of prostaglandin 15-hydroxydehydrogenase.

Hahn EL, Clancy KD, Tai HH, Ricken JD, He LK, Gamelli RL.

J Trauma. 1998 May;44(5):777-81; discussion 781-2.

PMID:
9603077
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk